As of 2024-12-12, the Relative Valuation of Albireo Pharma Inc (ALBO) is (74.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.15 USD, the upside of Albireo Pharma Inc based on Relative Valuation is -268.6%.
The range of the Relative Valuation is (32.24) - (115.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.0x - 18.3x | 11.6x |
| Forward P/E multiples | 5.1x - 18.7x | 11.9x |
| Fair Price | (32.24) - (115.69) | (74.44) |
| Upside | -173.0% - -362.0% | -268.6% |
| Date | P/E |